Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 19/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | CNR2 | P34972 | 5/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5405586 | 0.92 | CNR2 (0.49) | CNR1CNR2 | |
| SCHEMBL5377317 | 0.89 | CNR1 (0.42) | CNR1ALDH1A1CYP2D6CNR2 | |
| SCHEMBL5409614 | 0.89 | CNR1 (0.48) | CNR1ALDH1A1CYP2D6CNR2 | |
| SCHEMBL5399599 | 0.84 | CNR1 (0.47) | CNR1CNR2 | |
| SCHEMBL5372895 | 0.83 | CNR1 (0.41) | CNR1ALDH1A1CYP2D6CNR2 | |
| SCHEMBL5422248 | 0.82 | CNR1 (0.47) | CNR1CNR2 | |
| SCHEMBL5399589 | 0.81 | CNR1 (0.64) | CNR1CNR2 | |
| SCHEMBL5405535 | 0.80 | CNR1 (0.49) | CNR1CNR2 | |
| SCHEMBL5373810 | 0.78 | CNR1 (0.52) | CNR1CNR2 | |
| SCHEMBL5402027 | 0.77 | CNR1 (0.60) | CNR1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070275964-A1 | CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | PFIZER, INC. | 2007-11-29 | — | — | US | claimed |
| US-20040214837-A1 | Cannabinoid receptor ligands and uses thereof | PFIZER INC. | 2004-10-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040214837-A1 | Cannabinoid receptor ligands and uses thereof | CNR1, CNR2, GPR18 | CNR1 1/4885ALDH1A1 1683/4885CYP2D6 1363/4885 |
| US-20070275964-A1 | CANNABINOID RECEPTOR LIGANDS AND USES THEREOF | CNR1, CNR2, GPR18 | CNR1 1/4885ALDH1A1 1926/4885CYP2D6 1404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.